Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...

New Verizon Shine Loyalty Program Seeks to Reward Longtime Subscribers ...

Substack wants to simplify the search for sponsorship revenue for its thousands of newsletter writers. The platform on Monday ...

The Burlington County Library System offers its cardholders free access to more than three dozen different museums, zoos and ...

U.S. and Iranian negotiators were in Switzerland on Sunday for talks on their interim agreement to end the Iran war.

Rural communities across Ohio face no shortage of challenges. From aging infrastructure and limited broadband access to tight ...

Some Long Island parents are questioning the benefits of the i-Ready K-8 educational program, which offers online lessons and ...

Public debate over gifted education tends to focus on fairness. Who gets to be called “gifted” and what sort of extras do ...

Vice President JD Vance and Iran officials opened negotiations in Switzerland aimed at turning a fragile framework agreement ...